Literature DB >> 21178782

Hypertension and sexual dysfunction: time to act.

Margus Viigimaa1, Michael Doumas, Charalampos Vlachopoulos, Panagiota Anyfanti, Jacek Wolf, Krzysztof Narkiewicz, Giuseppe Mancia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21178782     DOI： 10.1097/HJH.0b013e328342c659

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  15 in total

1.  Sexual functioning of men and women with severe obesity before bariatric surgery.

Authors:  Kristine J Steffen; Wendy C King; Gretchen E White; Leslee L Subak; James E Mitchell; Anita P Courcoulas; David R Flum; Gladys Strain; David B Sarwer; Ronette L Kolotkin; Walter Pories; Alison J Huang
Journal:  Surg Obes Relat Dis       Date:  2016-09-28       Impact factor: 4.734

2.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

Review 3.  Management of erectile dysfunction in hypertension: Tips and tricks.

Authors:  Margus Viigimaa; Charalambos Vlachopoulos; Antonios Lazaridis; Michael Doumas
Journal:  World J Cardiol       Date:  2014-09-26

Review 4.  Gender differences in hypertension: myths and reality.

Authors:  Michael Doumas; Vasilios Papademetriou; Charles Faselis; Peter Kokkinos
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

5.  Predictors of impaired quality of life in patients with rheumatic diseases.

Authors:  Panagiota Anyfanti; Areti Triantafyllou; Panagiotis Panagopoulos; Georgios Triantafyllou; Athina Pyrpasopoulou; Sophia Chatzimichailidou; Nikolaos Koletsos; Ioannis Botis; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2015-12-23       Impact factor: 2.980

Review 6.  Antihypertensive treatment and sexual dysfunction.

Authors:  Athanasios Manolis; Michael Doumas
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

7.  Effects of chronic type 5 phosphodiesterase inhibition on penile microvascular reactivity in hypertensive patients with erectile dysfunction: a randomized crossover placebo-controlled trial.

Authors:  Valéria Verri; Alessandro R Nascimento; Andrea A Brandao; Eduardo Tibirica
Journal:  J Hum Hypertens       Date:  2020-05-04       Impact factor: 3.012

Review 8.  Hypertension and reproductive dysfunction: a possible role of inflammation and inflammation-associated lymphangiogenesis in gonads.

Authors:  Shobana Navaneethabalakrishnan; Bethany L Goodlett; Alexandra H Lopez; Joseph M Rutkowski; Brett M Mitchell
Journal:  Clin Sci (Lond)       Date:  2020-12-23       Impact factor: 6.876

9.  Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats.

Authors:  Chenchen Zhuang; Wenjuan Wang; Runmin Sun; Miaomiao Qi; Jing Yu
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

10.  Erectile dysfunction and target organ damage in the early stages of hypertension.

Authors:  Apostolos Kakkavas; Costas Tsioufis; Dimitris Tsiachris; Costas Thomopoulos; Kyriakos Dimitriadis; Anastasios Milkas; Dimitrios Alexopoulos; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-11       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.